863 related articles for article (PubMed ID: 22189569)
1. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
[TBL] [Abstract][Full Text] [Related]
2. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
Meyer zu Horste G; Miesbach TA; Muller JI; Fledrich R; Stassart RM; Kieseier BC; Coleman MP; Sereda MW
Neurobiol Dis; 2011 Apr; 42(1):1-8. PubMed ID: 21168501
[TBL] [Abstract][Full Text] [Related]
3. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
[TBL] [Abstract][Full Text] [Related]
5. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
Meyer zu Horste G; Prukop T; Liebetanz D; Mobius W; Nave KA; Sereda MW
Ann Neurol; 2007 Jan; 61(1):61-72. PubMed ID: 17262851
[TBL] [Abstract][Full Text] [Related]
6. Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A?
Meekins GD; Emery MJ; Weiss MD
J Peripher Nerv Syst; 2004 Sep; 9(3):177-82. PubMed ID: 15363066
[TBL] [Abstract][Full Text] [Related]
7. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
Kobsar I; Hasenpusch-Theil K; Wessig C; Müller HW; Martini R
J Neurosci Res; 2005 Sep; 81(6):857-64. PubMed ID: 16041800
[TBL] [Abstract][Full Text] [Related]
8. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.
LeGuern E; Gouider R; Mabin D; Tardieu S; Birouk N; Parent P; Bouche P; Brice A
Ann Neurol; 1997 Jan; 41(1):104-8. PubMed ID: 9005872
[TBL] [Abstract][Full Text] [Related]
9. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A.
Yoshikawa H; Nishimura T; Nakatsuji Y; Fujimura H; Himoro M; Hayasaka K; Sakoda S; Yanagihara T
Ann Neurol; 1994 Apr; 35(4):445-50. PubMed ID: 7512319
[TBL] [Abstract][Full Text] [Related]
11. Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease.
Nobbio L; Gherardi G; Vigo T; Passalacqua M; Melloni E; Abbruzzese M; Mancardi G; Nave KA; Schenone A
Eur J Neurosci; 2006 Mar; 23(6):1445-52. PubMed ID: 16553608
[TBL] [Abstract][Full Text] [Related]
12. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
[TBL] [Abstract][Full Text] [Related]
13. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
14. Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease.
Grandis M; Leandri M; Vigo T; Cilli M; Sereda MW; Gherardi G; Benedetti L; Mancardi G; Abbruzzese M; Nave KA; Nobbio L; Schenone A
Exp Neurol; 2004 Nov; 190(1):213-23. PubMed ID: 15473994
[TBL] [Abstract][Full Text] [Related]
15. Congenital pes cavus in a Charcot-Marie-tooth disease type 1A newborn.
Fusco C; Frattini D; Scarano A; Giustina ED
Pediatr Neurol; 2009 Jun; 40(6):461-4. PubMed ID: 19433282
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
Bird TD; Kraft GH; Lipe HP; Kenney KL; Sumi SM
Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
[TBL] [Abstract][Full Text] [Related]
17. Prolonged high frequency electrical stimulation is lethal to motor axons of mice heterozygously deficient for the myelin protein P₀ gene.
Alvarez S; Moldovan M; Krarup C
Exp Neurol; 2013 Sep; 247():552-61. PubMed ID: 23439028
[TBL] [Abstract][Full Text] [Related]
18. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.
Passage E; Norreel JC; Noack-Fraissignes P; Sanguedolce V; Pizant J; Thirion X; Robaglia-Schlupp A; Pellissier JF; Fontés M
Nat Med; 2004 Apr; 10(4):396-401. PubMed ID: 15034573
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
Barisić N; Mihatov I
Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
[TBL] [Abstract][Full Text] [Related]
20. Normal nerve striations are altered in the trembler-J mouse, a model of Charcot-Marie-Tooth disease.
Power BJ; O'reilly G; Murphy R; Murphy KJ; Pickering M; Jones JF
Muscle Nerve; 2015 Feb; 51(2):246-52. PubMed ID: 24890015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
